Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationCTIS Now Live
New EU rules for safe and high-quality medicines for animals become effective
Improving information for research participants - a blog by Leni Sivey
Making transparency happen - a blog by Dr Naho Yamazaki, Head of Policy and Engagement
ICH E9(R1) Estimands and Sensitivity Analysis in Clinical Trials
MHRA E-learning modules: medicines, updated
MHRA Guidance - Oversight and monitoring activities
Guidance - Risk-Adapted Approach to clinical trials and Risk Assessments
Public Consultation on new Clinical Trials Legislation
Regulator’s experience of clinical trials during the Covid-19 pandemic (Part 1) – our initial response